内科医师参与头颈游离组织移植患者管理能否改善结局?
本研究为回顾性队列研究,纳入2014至2022年接受头颈肿瘤切除及游离组织移植的362例患者,比较2018年9月前后内科住院医师服务(MHS)常规参与与按需会诊对住院结局的影响。结果显示,常规参与使转至更高护理级别的风险减半,但对30天再入院、90天死亡率和住院时长无显著影响。
要点
- MHS常规参与使转至更高护理级别的风险降低7.4%(95%CI -13.7至-1.02,p=0.02)。
- 30天再入院风险差为-4.4%(95%CI -14.0至5.3%,p=0.36),无统计学意义。
- 90天死亡率风险差为2.4%(95%CI -4.1至8.8,p=0.49),住院时长减少1.2天(95%CI -3.9至1.5,p=0.39),均无统计学意义。
核心结论
- MHS参与头颈游离组织移植患者的管理使转至更高护理级别的相对风险减半。
- 对死亡率、再入院或住院时长无显著影响。
研究设计与样本
- 回顾性队列研究,纳入2014至2022年接受头颈肿瘤切除及游离组织移植的362例患者。
- 2018年9月起MHS常规参与(干预后),此前按需会诊(干预前),干预前组占32.9%。
- 采用线性回归和广义线性模型分析。
主要发现
- 转至更高护理级别的风险差为-7.4%(95%CI -13.7至-1.02,p=0.02)。
- 30天再入院风险差为-4.4%(95%CI -14.0至5.3%,p=0.36)。
- 90天死亡率风险差为2.4%(95%CI -4.1至8.8,p=0.49)。
- 干预后住院时长减少1.2天(95%CI -3.9至1.5,p=0.39)。
临床怎么用
- 可考虑将MHS常规参与作为头颈游离组织移植患者术后医疗管理的策略,以降低转至更高护理级别的风险。
- 该策略对再入院、死亡率和住院时长的影响不显著,需结合其他措施综合评估。
局限性
- 回顾性研究设计可能存在混杂偏倚。
- 作者指出需进一步研究确认 findings。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate whether routine involvement of the medical hospitalist service (MHS) in postoperative medical management of head and neck cancer (HNC) patients undergoing major ablative head and neck surgery with free tissue transfer (FTT) improves inpatient outcomes. METHODS: This is a retrospective cohort study. Patients undergoing FTT after head and neck oncologic surgery between 2014 and 2022 were identified. Starting September 2018, MHS were involved in the medical care of every FTT patient (post-intervention). Prior to that, MHS were consulted on an as-needed basis (pre-intervention). Outcomes studied included transfer to a higher level of care (LOC), length of hospital stay (LOHS), 30-day readmission, and 90-day mortality. Data were analyzed using linear regression and generalized linear models. RESULTS: A total of 362 patients were included in this study (mean age 62.3 ± 10.5 and 30.1% females), 32.9% of the cohort being in the pre-intervention group. When comparing the post-intervention to pre-intervention groups, the risk difference (RD) for: (1) transfer to higher LOC was -7.4% (95% CI = -13.7 to -1.02, p = 0.02); (2) 30-day readmission was -4.4% (95% CI = -14.0 to 5.3%, p = 0.36); and (3) 90-day mortality was 2.4% (95% CI = -4.1 to 8.8, p = 0.49). Post-intervention, the LOHS decreased by 1.2 days compared to pre-intervention (95% CI = -3.9 to 1.5, p = 0.39). CONCLUSION: Involvement of MHS in the care of patients undergoing FTT halved the relative risk of transfer to higher LOC. There was no significant effect on mortality, readmission, or hospital stay. Further studies are needed to confirm our findings.
引用
- Ziltzer RS, Bulbul MG, Barry E, et al. Does Involvement of Medicine in Care of Head and Neck Free Tissue Transfer Patients Improve Outcomes? Laryngoscope. 2026. PMID: 42244039. doi:10.1002/lary.70659
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。